Clin Res Cardiol (2022). https://doi.org/10.1007/s00392-022-02002-5

Effects of atrial fibrillation on the human ventricle
S. Pabel1, M. Knierim2, T. Stehle1, F. Alebrand2, M. Paulus1, M. Sieme3, M. Herwig4, T. Körtl1, B. Wenner2, S. Ljubojevic-Holzer5, N. Dybkova2, S. Sedej5, D. Scherr5, C. Brochhausen6, G. Hasenfuß2, L. S. Maier1, N. Hamdani3, K. Streckfuß-Bömeke7, S. T. Sossalla1
1Klinik und Poliklinik für Innere Med. II, Kardiologie, Universitätsklinikum Regensburg, Regensburg; 2Herzzentrum, Klinik für Kardiologie und Pneumologie, Universitätsmedizin Göttingen, Göttingen; 3Forschungslabor Molekulare Kardiologie, Kath. Klinikum Bochum, Bochum; 4Molekulare und Experimentelle Kardiologie, Ruhr-Universität Bochum, Bochum; 5Klinische Abteilung für Kardiologie, LKH-Univ. Klinikum Graz - Universitätsklinik für Innere Medizin, Graz, AT; 6Institut für Pathologie, Universitätsklinikum Regensburg, Regensburg; 7Institut für Pharmakologie und Toxikologie, Universitätsklinikum Würzburg, Würzburg;

Introduction: Atrial fibrillation (AF) and heart failure (HF) often coexist, but their interaction is poorly understood. Clinical data indicate that the arrhythmic component of AF may contribute to left ventricular (LV) dysfunction. This study investigated the effects of AF on the human LV.

Methods and Results: LV myocardium from patients with preserved LV function (EF>50%) with sinus rhythm (SR, n=31) or rate-controlled AF (n=24) obtained during surgery for aortic stenosis was studied. LV myocardium from SR and AF patients showed no differences in fibrosis. In functional studies, systolic Ca2+ transient amplitude of isolated human LV cardiomyocytes (CM) was reduced in AF patients, while diastolic Ca2+ levels and Ca2+ transient kinetics were unaltered. These results were confirmed in LV CM from non-failing donors with AF (n=4) vs. SR (n=8). In addition, normofrequent AF was simulated in vitro using arrhythmic or rhythmic electrical culture pacing (both at 60 bpm). After 24h of AF-simulation, human LV CM from non-failing donors (n=9) showed also an impaired Ca2+ transient amplitude. For a standardized chronic AF-simulation, human iPSC-CM (n=22 differentiations/5 individuals) were utilized as a translational model. 7 days of AF-simulation similarly caused reduced systolic Ca2+ transient amplitude and sarcoplasmic reticulum Ca2+ load, which could be explained by an increased diastolic Ca2+ leak. Moreover, cytosolic Na+ concentration was elevated, and action potential duration was prolonged after AF-simulation. We detected an increased late Na+ current as a potential trigger for the detrimentally altered Ca2+/Na+-interplay in iPSC-CM after AF-simulation. Mechanistically, oxidative stress markers were higher in the LV of AF patients. Ca2+/calmodulin-dependent protein kinase IIδ (CaMKII) was found to be more oxidized at Met281/282 in the LV of AF patients leading to an increased CaMKII activity. Consequently, RyR2 phosphorylation was elevated, which likely underlies the depression of LV Ca2+ handling in AF. CaMKII inhibition and ROS scavenging during 7 days of AF-simulation prevented the impaired systolic Ca2+ handling in iPSC-CM.

Conclusions: Here we could demonstrate that AF per se impairs human LV excitation-contraction coupling via increases of oxidative stress and CaMKII activity in different patient populations and human models. Thus, this translational study firstly reveals the detrimental effects and mechanisms of AF in the absence of tachycardia on the human LV.


https://dgk.org/kongress_programme/jt2022/aP1933.html